INFeD (Actavis Pharma, Inc.)


Welcome to the PulseAid listing for the INFeD drug offered from Actavis Pharma, Inc.. This Iron [Chemical/Ingredient],Parenteral Iron Replacement [EPC],Phosphate Binder [EPC],Phosphate Chelating Activity [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Actavis Pharma, Inc.
NON-PROPRIETARY NAME: Iron Dextran
SUBSTANCE NAME: IRON DEXTRAN
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Iron [Chemical/Ingredient],Parenteral Iron Replacement [EPC],Phosphate Binder [EPC],Phosphate Chelating Activity [MoA]
ROUTE: INTRAMUSCULAR; INTRAVENOUS
DOSAGE FORM: INJECTION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 1974-04-29
END MARKETING DATE: 0000-00-00


INFeD HUMAN PRESCRIPTION DRUG Details:

Item DescriptionINFeD from Actavis Pharma, Inc.
LABELER NAME: Actavis Pharma, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 50(mg/mL)
START MARKETING DATE: 1974-04-29
END MARKETING DATE: 0000-00-00
PRODUCT ID: 52544-931_aead060b-cb47-4163-a1d8-8829837f2952
PRODUCT NDC: 52544-931
APPLICATION NUMBER: NDA017441

Other IRON DEXTRAN Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Actavis Pharma, Inc.INFeD
American Regent, Inc.Dexferrum
General Injectables & Vaccines, IncInfed